Chao, Chih-Jia
Zhang, Endong
Trinh, Duong N.
Udofa, Edidiong https://orcid.org/0000-0002-2164-1136
Lin, Hanchen
Silvers, Caylee
Huo, Jiawei https://orcid.org/0000-0002-9695-513X
He, Shan
Zheng, Jingtian
Cai, Xiaoying
Bao, Qing https://orcid.org/0009-0007-8213-5492
Zhang, Luyu
Phan, Philana
Elgendy, Sara M. https://orcid.org/0000-0002-7312-8692
Shi, Xiangqian
Burdette, Joanna E. https://orcid.org/0000-0002-7271-6847
Lee, Steve Seung-Young https://orcid.org/0000-0003-1349-3759
Gao, Yu
Zhang, Peng https://orcid.org/0000-0001-9856-7571
Zhao, Zongmin https://orcid.org/0000-0001-8979-844X
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM150507)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R21CA291723, P50CA221747, R37CA266487)
Article History
Received: 17 September 2024
Accepted: 2 May 2025
First Online: 16 May 2025
Competing interests
: C.-J.C. and Z.Z. are inventors on a patent application with aspects related to this work (titled “Antigen capturing nanoparticle engineered dendritic cells for in situ cancer immunization”, US Provisional Application no. 63/682,533) filed by the University of Illinois Chicago. The remaining authors declare no competing interests.